Investigation on circulating tumor cells starts here

Investigation on circulating tumor cells starts here

Screencell size-isolation device features

  • Easy-to-use, compact, and single-use device
  • Cell size-based isolation device
  • Antibody-independent (ex. EpCam independent)
  • Ability to work on living and fixed cells
  • No instrumentation required
  • Fast isolation process <3 min
  • High recovery rate
  • Technology applicable to all types of solid tumors
  • Access to a wide range of technologies for precision medicine
  • CTCs can be isolated on glass slides compatible with automatic staining systems
learn more
...
...

Contact form

You can also fill the form below to send us a message.
We will answer you shortly



Partnerships

ScreenCell has many active and ongoing partnerships with different research centers, universities, and hospitals around the globe. We are ready to collaborate with you in your scientific or clinical projects. Please do not hesitate to contact us for further inquiries.

Learn more

[ NEWS ]

[ 2021 April, 07 ]
Non-Metastatic Esophageal Adenocarcinoma : Circulating Tumor Cells in the Course of Multimodal Tumor Treatment

Non-Metastatic Esophageal Adenocarcinoma : Circulating Tumor Cells in the Course of Multimodal Tumor Treatment

learn more
[ 2020 May, 28 ]
Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy

Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy

learn more
[ 2020 April, 15 ]
Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis

Detection of circulating tumor cells in patients with laryngeal cancer using ScreenCell: Comparative pre- and post-operative analysis and association with prognosis

learn more